Literature DB >> 28323999

Metabolically Healthy Obesity and Ischemic Heart Disease: A 10-Year Follow-Up of the Inter99 Study.

Louise Hansen1, Marie K Netterstrøm1, Nanna B Johansen1,2,3, Pernille F Rønn1,4, Dorte Vistisen1, Lise L N Husemoen3, Marit E Jørgensen1,5, Naja H Rod6, Kristine Færch1.   

Abstract

Context: Recent studies have suggested that a subgroup of obese individuals is not at increased risk of obesity-related complications. This subgroup has been referred to as metabolically healthy obese. Objective: To investigate whether obesity is a risk factor for development of ischemic heart disease (IHD) irrespective of metabolic health. Design: In all, 6238 men and women from the Danish prospective Inter99 study were followed during 10.6 (standard deviation = 1.7) years. Setting: General community. Participants: Participants were classified according to body mass index and four metabolic risk factors (low high-density lipoprotein cholesterol, elevated blood pressure, triglycerides, and fasting plasma glucose). Metabolically healthy individuals were defined as having no metabolic risk factors, and metabolically unhealthy individuals were defined as having a minimum of one. Main Outcome Measures: IHD.
Results: During follow-up, 323 participants developed IHD. Metabolically healthy obese men had increased risk of IHD compared with metabolically healthy normal-weight men [hazard ratio (HR), 3.1; 95% confidence interval (CI), 1.1 to 8.2)]. The corresponding results for women were less pronounced (HR, 1.8; 95% CI, 0.7 to 4.8). Being metabolically healthy but overweight was not associated with higher risk of IHD in men (HR, 1.1; 95% CI, 0.5 to 2.4), and in women the risk was only slightly increased and insignificant (HR, 1.5; 95% CI, 0.8 to 3.0). A substantial proportion of metabolically healthy individuals became metabolically unhealthy after 5 years of follow-up. When these changes in exposure status were taken into account, slightly higher risk estimates were found. Conclusions: Being obese is associated with higher incidence of IHD irrespective of metabolic status, and we question the feasibility of denoting a subgroup of obese individuals as metabolically healthy.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28323999     DOI: 10.1210/jc.2016-3346

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  The Influence of Sex on Cardiac Physiology and Cardiovascular Diseases.

Authors:  Yu Zhang; Bin Liu; Ranzun Zhao; Saidan Zhang; Xi-Yong Yu; Yangxin Li
Journal:  J Cardiovasc Transl Res       Date:  2019-07-01       Impact factor: 4.132

2.  Risk of hypertension among different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Atieh Mirzababaei; Hadis Mozaffari; Sakineh Shab-Bidar; Alireza Milajerdi; Kurosh Djafarian
Journal:  J Hum Hypertens       Date:  2018-12-19       Impact factor: 3.012

3.  The long-term prognosis of heart diseases for different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Atieh Mirzababaei; Kurosh Djafarian; Hadis Mozafari; Sakineh Shab-Bidar
Journal:  Endocrine       Date:  2019-01-22       Impact factor: 3.633

4.  Circulating prolactin level is increased in metabolically healthy obesity.

Authors:  Jia Liu; Lin Zhang; Jing Fu; Qiu Wang; Guang Wang
Journal:  Endocr Connect       Date:  2021-04-29       Impact factor: 3.335

5.  Costs associated with depression and obesity among cardiovascular patients: medical expenditure panel survey analysis.

Authors:  Felipe Saia Tápias; Victor Henrique Oyamada Otani; Daniel Augusto Corrêa Vasques; Thais Zelia Santos Otani; Ricardo Riyoiti Uchida
Journal:  BMC Health Serv Res       Date:  2021-05-06       Impact factor: 2.655

6.  Modulatory Effects of Guarana (Paullinia cupana) on Adipogenesis.

Authors:  Natália da Silva Lima; Erica de Paula Numata; Leonardo Mendes de Souza Mesquita; Pollyana Hammoud Dias; Wagner Vilegas; Alessandra Gambero; Marcelo Lima Ribeiro
Journal:  Nutrients       Date:  2017-06-20       Impact factor: 5.717

7.  Increased Levels of Cardiac Troponin I in Subjects with Extremely Low B-type Natriuretic Peptide Levels.

Authors:  Satoshi Sugawa; Izuru Masuda; Kiminori Kato; Michihiro Yoshimura
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

8.  Sex differences in the associations between adiposity distribution and cardiometabolic risk factors in overweight or obese individuals: a cross-sectional study.

Authors:  Yide Yang; Ming Xie; Shuqian Yuan; Yuan Zeng; Yanhui Dong; Zhenghe Wang; Qiu Xiao; Bin Dong; Jun Ma; Jie Hu
Journal:  BMC Public Health       Date:  2021-06-26       Impact factor: 3.295

Review 9.  Management of Obesity in Cardiovascular Practice: JACC Focus Seminar.

Authors:  Jean-Pierre Després; André C Carpentier; André Tchernof; Ian J Neeland; Paul Poirier
Journal:  J Am Coll Cardiol       Date:  2021-08-03       Impact factor: 27.203

10.  Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: A cohort study.

Authors:  Meng Gao; Jun Lv; Canqing Yu; Yu Guo; Zheng Bian; Ruotong Yang; Huaidong Du; Ling Yang; Yiping Chen; Zhongxiao Li; Xi Zhang; Junshi Chen; Lu Qi; Zhengming Chen; Tao Huang; Liming Li
Journal:  PLoS Med       Date:  2020-10-30       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.